维维股份(600300.SH)拟投资1亿元设立全资子公司维维生物科技

Core Viewpoint - The company, Weiweijia (维维股份), plans to invest 100 million yuan to establish a wholly-owned subsidiary, Weiweijia Biotechnology, to optimize resource allocation and enhance its core business strategy [1] Group 1: Investment and Strategic Goals - The investment aims to deepen the company's core business strategic layout and improve market-oriented operational efficiency [1] - Establishing the subsidiary is aligned with the company's long-term development plan and is expected to lead the business towards higher value dimensions [1] - The move is intended to continuously consolidate and strengthen the company's core competitiveness, creating a high-level value creation platform [1]